The present invention is directed to compounds having the Formula (I), (Ia) or (Ib), compositions thereof and methods for the treatment of a condition associated with a dysfunction in proteostasis.
3-SUBSTITUIERTE 3,4-DIHYDRO-THIENO¬2,3-D PYRIMIDIN-4-ONE-DERIVATE, IHRE HERSTELLUNG UND VERWENDUNG
申请人:Abbott GmbH & Co. KG
公开号:EP1572698B1
公开(公告)日:2008-07-02
[EN] PROTEASOME ACTIVITY ENHANCING COMPOUNDS<br/>[FR] COMPOSÉS RENFORÇANT L'ACTIVITÉ DES PROTÉASOMES
申请人:PROTEOSTASIS THERAPEUTICS INC
公开号:WO2013112699A2
公开(公告)日:2013-08-01
The present invention is directed to compounds having the Formula (I), (Ia) or (Ib), compositions thereof and methods for the treatment of a condition associated with a dysfunction in proteostasis.